Create Alert
Watchlist

Ambalal Sarabhai Enterprises

₹26.78
-0.08 (0.30%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
26.36
Prev. Close
26.86
Volume
20,195
Total traded value
0.05 Cr
Upper Circuit
32.23
Lower Circuit
21.49

Fundamentals

Market Cap₹206Cr
ROE10.60%
P/E Ratio(TTM)21.32
EPS(TTM)1.26
P/B Ratio1.40
Dividend Yield0.00%
Industry P/E32.95
Book Value19.25
Debt to Equity0.32
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Ambalal Sarabhai

Ambalal Sarabhai Enterprises Limited is a diversified company with core operations in the pharmaceuticals and electronics manufacturing sectors, supported by its subsidiaries and joint ventures. Its focused subsidiaries have recorded significant progress in key areas including Active Pharmaceutical Ingredients manufacturing, Molecular Diagnostics, and niche Effervescent products. The group maintains a clear emphasis on disease-based solutions, leveraging its robust technological capabilities to drive future growth in both healthcare and electronics. Its joint venture, Vovantis, operates a USFDA-approved manufacturing plant in Ranoli, with an increased focus on products for the USA and European markets. Another key subsidiary, Synbiotics, is a USFDA inspected company that manufactures an antifungal active ingredient, Amphotericin B, for an expanding global market. Furthermore, its Asence subsidiary specializes in supplying quality pharmaceutical preparations to international markets, with over 100 products registered worldwide.;
Parent OrganisationAmbalal Sarabhai Enterprises Limited
Managing DirectorMr. Mohal K. Sarabhai
Founded1977
BSE Symbol500009

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Retail And Others
68.31%
Promoters
31.35%
Foreign Institutions
0.34%
Other Domestic Institutions
0.01%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.50
Emcure Pharmaceuticals
NA
(0.00%)
32.62
Wockhardt
NA
(0.00%)
-424.60
Cohance Lifesciences
NA
(0.00%)
64.50
2025
12
Nov
Quarterly Result
Release date
11
Aug
Quarterly Result
Release date
30
May
Annual Result
Release date
14
Feb
Quarterly Result
Release date
2024
12
Nov
Quarterly Result
Release date
9
Aug
Quarterly Result
Release date
24
May
Result
Release date
Events calendar
View upcoming events in other stocks